人肺腺癌细胞PC-9FH0083
价格：￥电议
品牌名称：富衡型号：FH0083 原产地：中国大陆 更新时间：2026/10/21 7:56:21
产品摘要：PC-9细胞系源自一位肺腺癌患者的肿瘤组织。该细胞是一种非常重要的人肺腺癌细胞系，因其明确的分子特征和与临床治疗的高度相关性，在肺癌基础研究与药物开发中扮演着关键角色。
支付方式：
- 支付宝 微信 银行转账
产品完善度： 访问次数：562
企业档案
会员类型：旗舰版
已获得阿仪网信誉 等级评定
61成长值
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
阿仪网旗舰版会员：3年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
参观次数：630295
详细内容
| 产品名称 | 人肺腺癌细胞；PC-9 (STR) |
|---|---|
| 品牌 | FuHeng |
| 英文名 | PC-9 (STR) |
| 货号 | FH0083 |
| 规格 | 1×10⁶cells/T25培养瓶 |
| 价格 | 1500.0 |
| 培养 | RPMI1640+10%FBS |
| 别称 | PC9; PC-9/S1; PC-9S1 |
| 形态特征 | 上皮样 |
| 生长特性 | 贴壁生长 |
| 培养条件 | 气相：空气，95%；CO2,5%温度：37℃ |
| 传代方法 | 1：2传代 |
| 组织来源 | 肺腺癌 |
| 细胞简介 | PC-9 细胞系是源自日本肺腺癌患者的经典细胞模型 |
| 特征特性 | Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: MD Anderson Cell Lines Project. From: Immuno-Biological Laboratories (IBL); Tokyo; Japan. |
| 培养基 | PC-9完全培养基 |
上海衡生物科技有限公司
上海富衡生物科技有限公司（以下简称“富衡”）是主要从事生物科技，医药科技领域内的技术开发，技术咨询，技术服务的高新技术企业。是一家专注于细胞相关技术，服务及产品的高科技生命科学和生物技术领域企业。
富衡提供专业的细胞鉴定服务（采用ATCC细胞鉴定准－－STR基因分型技术），并建立完善鉴定，种类齐全的细胞资源库，能为广大科研工作者在发表高质量文章时提供可靠的“细胞鉴定依据”。公司拥有一个蓬勃朝气的年轻团队，不断进取，我们密切注视细胞技术领域的发展，并且于员工的技术和素质培训。团队中博士硕士以上学历人士达80％，有很强的技术支持及研发能力。
专注于细胞培养 PARTNERS 合作伙伴
富衡相关文献
| 论文标题 | DOI | 发表时间 | 期刊 | 影响因子 | 作者列表 |
| DNMT3b promotes proliferation and invasion by mediating HOPX DNA methylation in lung cancer | 10.1016/j.isci.2025.114347 | 2025-12-04 | iScience | 4.1 | Kelei Guan, Songfeng Zhao, Guizhen Zhang, Yun Wang, Dongdong Song, Yanxia Ding |
| A pathological role of O-GlcNAcylation-driven TR11B production and function in lung adenocarcinoma | 10.1016/j.devcel.2025.08.010 | 2025-09-09 | DEVELOPMENTAL CELL | 8.7 | Shiyu Qiu, Lifang Ma, Keke Yu, Xin Xu, Xiao Zhang, Wenjun Yu, Kai Wang, Xiaoting Tian, Yayou Miao, Yikun Wang, Wanxin Guo, Xiangfei Xue, Jiangtao Cui, Xuewen Yu, Rui Kang, Qianjun Zhou, Yongchun Yu, Daolin Tang, Jiayi Wang |
| Tumor-derived immunoglobulin-like tranｓcript 3 inhibition reshapes the immunosuppressive tumor microenvironment and potentiates programmed cell death ligand 1 blockade immunotherapy in lung adenocarcinoma | 10.1016/j.tranon.2025.102381 | 2025-04-08 | Translational Oncology | 4.1 | Leirong Wang, Qing Li, Yanxin Sun, Shuyun Wang, Xuebing Fu, Xiufen Wang, Yan Zheng, Aiqin Gao, Yuping Sun, Juan Li |
| The mechanism of E3 ubiquitin ligase HERC1 regulating ferroptosis in lung adenocarcinoma cells | 10.1016/j.cancergen.2025.02.001 | 2025-02-03 | Cancer Genetics | 2.1 | Fei Ye, Yi Xu, Xujuan Zhu, Qifeng Ding, Yifei Wang, Songhua Lu, Yongbing Chen |
| Automated Laser-Assisted Single-Cell Sorting for Cell Functional and RNA Sequencing | 10.1021/acssensors.4c02417 | 2025-01-22 | ACS Sensors | 9.1 | Yuntong Wang, Ying Xue, Huan Wang, Yue Qu, Kunlong Zhang, Lindong Shang, Peng Liang, Fuyuan Chen, Xusheng Tang, Wei Luo, Lip Ket Chin, Shilun Feng, Bei Li |
| Heterogeneous nuclear ribonucleoprotein C promotes non-small cell lung cancer progression by enhancing XB130 mRNA stability and translation | 10.1186/s12935-025-03638-9 | 2025-01-13 | Cancer Cell International | 6.0 | Wang Qinrong, Gou Xuanjing, Liu Lingling, Deng Daolan, Zhao Yan, Zhou Jianjiang, Xie Yuan, Jiang Yinhui, Li Jianglun, Zhang Jian, Liu Ying |
| Prognostic and immunotherapeutic significances of M2 macrophage-related genes signature in lung cancer | 10.7150/jca.98044 | 2024-07-22 | Journal of Cancer | 3.3 | Wu Haixia, Yu Yilin, Wang Wei, Lin Gen, Lin Shaolin, Zhang Jiguang, Yu Zhaojun, Luo Jiewei, Ye Deju, Chi Wu, Lin Xing |
| CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1/HK2 axis | 10.1186/s12967-024-05284⁻⁷ | 2024-05-15 | Journal of Translational Medicine | 6.1 | Shao-Kun Yu, Tao Yu, Yu-Ming Wang, Ao Sun, Jia Liu, Kai-Hua Lu |
| Circ_0006949 as a potential non-invasive diagnosis biomarker promotes the proliferation of NSCLC cells via miR-4673/GLUL axis | 10.1016/j.bbadis.2024.167234 | 2024-05-13 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 4.2 | Changsen Bai, Chaomin Wang, Jialei Hua, Na Zhao, Tong Li, Wenxin Li, Wenhao Niu, Benfu Zhong, Shuaini Yang, Chunda Chen, Gang Zhao, Li Qiu, Zhansheng Jiang, Lifang Li, Yueguo Li, Hailong Wang |
| Gefitinib ｍmbedbolism-related lncRNAs for the prediction of prognosis, tumor microenvironment and drug sensitivity in lung adenocarcinoma | 10.1038/s41598-024-61175-3 | 2024-05-06 | Scientific Reports | 3.8 | Guo Zishun, Zhang Xin, Yang Dingtao, Hu Zhuozheng, Wu Jiajun, Zhou Weijun, Wu Shuoming, Zhang Wenxiong |
| The 3'‑untranslated region of XB130 regulates its mRNA stability and translational efficiency in non‑small cell lung cancer cells | 10.3892/ol.2023.14013 | 2023-08-17 | Oncology Letters | 2.9 | Qinrong Wang, Lingling Liu, Xuanjing Gou, Ting Zhang, Yan Zhao, Yuan Xie, Jianjiang Zhou, Ying Liu, Kewei Song |
| Exosome-derived circKIF20B suppresses gefitinib resistance and cell proliferation in non-small cell lung cancer | 10.1186/s12935-023-02974-y | 2023-07-02 | Cancer Cell International | 5.8 | Wei Si-Liang, Ye Jing-Jing, Sun Li, Hu Lei, Wei Yuan-Yuan, Zhang Da-Wei, Xu Meng-Meng, Fei Guang-He |
| LPCAT3 is tranｓcriptionally regulated by YAP/ZEB/EP300 and collaborates with ACSL4 and YAP to determine ferroptosis sensitivity | 10.1089/ars.2023.0237 | 2023-05-11 | ANTIOXIDANTS & REDOX SIGNALING | 6.6 | Mr. Jiangtao Cui, Dr. Yikun Wang, Ms. Xiaoting Tian, Ms. Yayou Miao, Prof. Lifang Ma, Ms. Congcong Zhang, Dr. Xin Xu, Dr. Jiayi Wang, Prof. Wentao Fang, Prof. Xiao Zhang |
| HnRNPAB is an independent prognostic factor in non‑small cell lung cancer and is involved in cell proliferation and ｍmbedstasis | 10.3892/ol.2023.13801 | 2023-04-12 | Oncology Letters | 2.9 | Qinrong Wang, Xuanjing Gou, Lingling Liu, Ting Zhang, Hang Yuan, Yan Zhao, Yuan Xie, Jianjiang Zhou, Kewei Song |
| A positive feedback circuit between RN7SK snRNA and m6A readers is essential for tumorigenesis | 10.1016/j.ymthe.2022.12.013 | 2022-12-24 | MOLECULAR THERAPY | 12.91 | Xin Xu, Lifang Ma, Xiao Zhang, Susu Guo, Wanxin Guo, Yikun Wang, Shiyu Qiu, Xiaoting Tian, Yayou Miao, Yongchun Yu, Jiayi Wang |
| Integrated Clinical and Prognostic Analysis of the m6A RNA Methylation Regulator YTHDF3 in Pan-Cancer and its Correlation with Cancer Cell Proliferation | 10.7150/jca.78403 | 2022-11-21 | Journal of Cancer | 4.478 | Cao Leiqun, Zeng Bingjie, Wang Yulan, Wang Xianzhao, Qin Yueyang, Zhang Congcong, Wu Mengyi, Wang Jiayi, Zhang Xiao, Ma Lifang |
| ISGylation of EMD promotes its interaction with PDHA to inhibit aerobic oxidation in lung adenocarcinoma | 10.1111/jcmm.17536 | 2022-09-07 | JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 5.295 | Congcong Zhang, Jiangtao Cui, Leiqun Cao, Xiaoting Tian, Yayou Miao, Yikun Wang, Shiyu Qiu, Wanxin Guo, Lifang Ma, Jinjing Xia, Xiao Zhang |
| N-mytistoyltransferase 1 and 2 are potential tumor suppressors and novel targets of miR-182 in human non-small cell lung carcinomas | 10.1016/j.lungcan.2022.07.021 | 2022-07-29 | LUNG CANCER | 6.081 | Tong Zhang, Arul Goel, Xin Xu, Yazhou Wu, Erjiang Tang, Fanping Zhang, Yuan Li, Hanhua Li, Yuchan Cai, Wenhao Weng |
| Tumour cells are sensitised to ferroptosis via RB1CC1-mediated tranｓcriptional reprogramming | 10.1002/ctm2.747 | 2022-02-27 | Clinical and Translational Medicine | 8.554 | Xiangfei Xue, Lifang Ma, Xiao Zhang, Xin Xu, Susu Guo, Yikun Wang, Shiyu Qiu, Jiangtao Cui, Wanxin Guo, Yongchun Yu, Fenyong Sun, Yi Shi, Jiayi Wang |
| Essential roles of exosome and circRNA_101093 on ferroptosis desensitization in lung adenocarcinoma | 10.1002/cac2.12275 | 2022-02-20 | Cancer Communications | 15.283 | Xiao Zhang, Yunhua Xu, Lifang Ma, Keke Yu, Yongjie Niu, Xin Xu, Yi Shi, Susu Guo, Xiangfei Xue, Yikun Wang, Shiyu Qiu, Jiangtao Cui, Hong Wang, Xiaoting Tian, Yayou Miao, Fanyu Meng, Yongxia Qiao, Yongchun Yu, Jiayi Wang |
| ELK1 Promotes Epithelial-Mesenchymal Transition and the Progression of Lung Adenocarcinoma by Upregulating B7-H3 | 10.1155/2021/2805576 | 2021-12-21 | Oxidative Medicine and Cellular Longevity | 6.543 | Ting-ting Yu, Tao Zhang, Fei Su, Ying-long Li, Li Shan, Xiao-ming Hou, Ruo-zheng Wang |
| Tranｓcriptional Repression of Ferritin Light Chain Increases Ferroptosis Sensitivity in Lung Adenocarcinoma | 10.3389/fcell.2021.719187 | 2021-10-26 | Frontiers in Cell and Developmental Biology | 6.684 | Wang Yikun, Qiu Shiyu, Wang Hong, Cui Jiangtao, Tian Xiaoting, Miao Yayou, Zhang Congcong, Cao Leiqun, Ma Lifang, Xu Xin, Qiao Yongxia, Zhang Xiao |
| tsRNA-5001a promotes proliferation of lung adenocarcinoma cells and is associated with postoperative recurrence in lung adenocarcinoma patients | 10.21037/tlcr-21-829 | 2021-10-01 | Translational Lung Cancer Research | 6.498 | Fang Hu, Yanjie Niu, Xiaowei Mao, Jiangtao Cui, Xiaoting Wu, Charles B. Simone, II, Hye Seon Kang, Wenxin Qin, Liyan Jiang |
| Knockdown of circ‑PVT1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the miR‑429/FOXK1 signaling axis | 10.3892/mmr.2021.12323 | 2021-07-29 | Molecular Medicine Reports | 2.952 | Limin Cao, Xuefeng Zhou, Xi Ding, Dongyun Gao |
| Trop2 binding IGF2R induces gefitinib resistance in NSCLC by remodeling the tumor microenvironment | 10.7150/jca.57711 | 2021-07-03 | Journal of Cancer | 4.207 | Xia Sun, Lizhou Jia, Tengqi Wang, Yulian Zhang, Wei Zhao, Xiangcheng Wang, Hao Chen |
| Targeting SLC3A2 subunit of system XC− is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma | 10.1016/j.freeradbiomed.2021.03.023 | 2021-03-27 | FREE RADICAL BIOLOGY AND MEDICINE | 7.376 | Lifang Ma, Xiao Zhang, Keke Yu, Xin Xu, Tianxiang Chen, Yi Shi, Yikun Wang, Shiyu Qiu, Susu Guo, Jiangtao Cui, Yayou Miao, Xiaoting Tian, Lutao Du, Yongchun Yu, Jinjing Xia, Jiayi Wang |
| Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma | 10.7150/thno.55482 | 2021-03-24 | Theranostics | 11.556 | Xiao Zhang, Keke Yu, Lifang Ma, Zijun Qian, Xiaoting Tian, Yayou Miao, Yongjie Niu, Xin Xu, Susu Guo, Yueyue Yang, Zhixian Wang, Xiangfei Xue, Chuanjia Gu, Wentao Fang, Jiayuan Sun, Yongchun Yu, Jiayi Wang |
| The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function | 10.1016/j.redox.2020.101801 | 2020-11-18 | Redox Biology | 9.986 | Lifang Ma, Tianxiang Chen, Xiao Zhang, Yayou Miao, Xiaoting Tian, Keke Yu, Xin Xu, Yongjie Niu, Susu Guo, Congcong Zhang, Shiyu Qiu, Yongxia Qiao, Wentao Fang, Lutao Du, Yongchun Yu, Jiayi Wang |
| Members of the miR‑30 family inhibit the epithelial‑to‑mesenchymal transition of non‑small‑cell lung cancer cells by suppressing XB130 expression levels | 10.3892/ol.2020.11929 | 2020-07-29 | Oncology Letters | 2.311 | Kewei Song, Yinhui Jiang, Yan Zhao, Yuan Xie, Jianjiang Zhou, Wenfeng Yu, Qinrong Wang |
热门标签：人肺腺癌细胞,PC-9,PC-9细胞
